ArticleOncoimmunology2012
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.
Erika Vacchelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
128 papers cite itlatest 60 shown
this papercites it
ArticleOncoimmunology2012
Erika Vacchelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.